Literature DB >> 4565638

Pseudomonas putrefaciens isolates from clinical specimens.

P S Riley, H W Tatum, R E Weaver.   

Abstract

A total of 109 cultures of Pseudomonas putrefaciens isolated from clinical specimens were studied. The cultures were separated into two groups. The majority of the group 1 isolates, comprising 31 cultures, were characterized by (i) growth in plain nutrient broth, but no growth in broth supplemented with NaCl at concentrations of 7% and above, (ii) no growth on Salmonella-Shigella (SS) agar, and (iii) production of acid from the carbohydrates, sucrose, maltose, arabinose, and dextrin. Most group 2 isolates, comprising 78 cultures, were (i) unable to grow in plain nutrient broth, but grew well in broth supplemented with NaCl at a concentration of 7 to 10%, (ii) able to grow on SS agar, and (iii) unable to produce detectable amounts of acid from any of the carbohydrates tested except for variable results with glucose and fructose.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4565638      PMCID: PMC380665          DOI: 10.1128/am.24.5.798-800.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Simplified tests for some amino acid decarboxylases and for the arginine dihydrolase system.

Authors:  V MØLLER
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  The Pseudomonas-Achromobacter group.

Authors:  H B MOORE; M J PICKETT
Journal:  Can J Microbiol       Date:  1960-02       Impact factor: 2.419

3.  Correlation of DNA base composition and metabolism of Pseudomonas putrefaciens isolates from food, human clinical specimens, and other sources.

Authors:  R E Levin
Journal:  Antonie Van Leeuwenhoek       Date:  1972       Impact factor: 2.271

4.  Potentially pathogenic, nonfermentative, H2S-producing gram-negative rod (1 b).

Authors:  A von Graevenitz; G Simon
Journal:  Appl Microbiol       Date:  1970-01
  4 in total
  27 in total

1.  Characteristics of weak H2S-producing isolates of Pseudomonas putrefaciens from human infections.

Authors:  R E Levin
Journal:  Antonie Van Leeuwenhoek       Date:  1975       Impact factor: 2.271

2.  Pseudomonas putrefaciens as a cause of septicemia in humans.

Authors:  U Schmidt; R Kapila; Z Kaminski; D Louria
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

3.  Association of Pseudomonas cepacia with chronic granulomatous disease.

Authors:  E J Bottone; S D Douglas; A R Rausen; G T Keusch
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

4.  Cellular fatty acids of Alcaligenes and Pseudomonas species isolated from clinical specimens.

Authors:  S B Dees; C W Moss
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

5.  Cultural and biochemical characteristics and fatty acid composition of Pseudomonas diminuta and Pseudomonas vesiculare.

Authors:  C M Kaltenbach; C W Moss; R E Weaver
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

6.  Recognition of Pseudomonas pickettii in the clinical laboratory: biochemical characterization of 62 strains.

Authors:  P S Riley; R E Weaver
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

7.  Pseudomonas putrefaciens as a cause of bacteremia in humans.

Authors:  J Vandepitte; J Debois
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

8.  Isolation of Pseudomonas putrefaciens in intra-abdominal sepsis.

Authors:  C Marne; R Pallarés; A Sitges-Serra
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

9.  Emended description of Kingella denitrificans (Snell and Lapage 1976): correction of the maltose reaction.

Authors:  D G Hollis; R E Weaver; P S Riley
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Cellular fatty acid composition of Pseudomonas marginata and closely associated bacteria.

Authors:  S B Dees; D G Hollis; R E Weaver; C W Moss
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.